An overview of the clinical efficacy of HFA-BDP in asthma.
Muir
J F
JF
Service de Pneumologie, CHU de ROUEN, France. Jean-Francois.Muir@chu-rouen.fr
D000287:Administration, Topical; D000335:Aerosol Propellants; D018927:Anti-Asthmatic Agents / Q000627:therapeutic use*; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D001249:Asthma / Q000188:drug therapy*; D001507:Beclomethasone / Q000627:therapeutic use*; D002626:Chemistry, Pharmaceutical; D005938:Glucocorticoids; D006801:Humans; D006845:Hydrocarbons, Fluorinated; D005466:Fluorocarbons
D000335:Aerosol Propellants; D018927:Anti-Asthmatic Agents; D000893:Anti-Inflammatory Agents; D001507:Beclomethasone; D005938:Glucocorticoids; D006845:Hydrocarbons, Fluorinated; C094049:apaflurane; D005466:Fluorocarbons